Cellectar Biosciences, Inc.
Cellectar Biosciences, Inc.（CLRB）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · CLRB · 截至 2026年6月9日
活动摘要
买入笔数
7
P-Purchase only
卖出笔数
0
近12个月
买卖比
∞
Buy/Sell (by trades)
整体情绪
Cellectar Biosciences, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
CLRB 季度内部人买卖趋势
CLRB 内幕交易卖出 · CLRB 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · CLRB CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
CLRB 高管卖出股份 · CLRB 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 7, 2026 | Longcor Jarrod COO | Purchase | 8,680 | $25K | Form 4 |
| May 7, 2026 | CARUSO JAMES V CEO · Director | Purchase | 8,680 | $25K | Form 4 |
| Dec 12, 2025 | NEIS JOHN Director | Sale | 198 | $732 | Form 4 |
| Jul 2, 2025 | CARUSO JAMES V CEO · Director | Purchase | 10,000 | $50K | Form 4 |
| Jul 2, 2025 | Longcor Jarrod COO | Purchase | 10,000 | $50K | Form 4 |
| Jul 2, 2025 | Kolean Chad J CFO | Purchase | 5,000 | $25K | Form 4 |
| Jan 10, 2025 | Longcor Jarrod COO | Purchase | 30,000 | $8K | Form 4 |
| Dec 8, 2023 | Lea Darrell Shane Chief Commercial Officer | Award | 39,599 | — | Form 4 |
| Dec 8, 2023 | Kolean Chad J CFO | Award | 42,554 | — | Form 4 |
| Dec 8, 2023 | Shustov Andrei Senior Vice President, Medical | Award | 47,856 | — | Form 4 |
| Dec 8, 2023 | Longcor Jarrod COO | Award | 42,927 | — | Form 4 |
| Dec 8, 2023 | CARUSO JAMES V President and CEO · Director | Award | 40,596 | — | Form 4 |
| Sep 14, 2021 | Swirsky Douglas J Director | Purchase | 25,000 | $26K | Form 4 |
| Sep 3, 2021 | DRISCOLL FREDERICK W Director | Purchase | 19,417 | $20K | Form 4 |
| Mar 4, 2021 | CARUSO JAMES V President and CEO · Director | Purchase | 5,100 | $9K | Form 4 |
| Dec 28, 2020 | CARUSO JAMES V President and CEO · Director | Purchase | 37,037 | $50K | Form 4 |
| Dec 28, 2020 | Longcor Jarrod Chief Business Officer | Purchase | 29,630 | $40K | Form 4 |
| Dec 28, 2020 | Elefant Dov CFO | Purchase | 7,407 | $10K | Form 4 |
| Jun 4, 2020 | HILL STEPHEN A Director | Purchase | 18,000 | $19K | Form 4 |
| Jun 5, 2020 | Elefant Dov CFO | Purchase | 4,348 | $5K | Form 4 |
| Jun 5, 2020 | Longcor Jarrod Chief Business Officer | Purchase | 65,218 | $75K | Form 4 |
| Jun 5, 2020 | CARUSO JAMES V President and CEO · Director | Purchase | 21,740 | $25K | Form 4 |
CARUSO JAMES V
President and CEO · Director
日期
Dec 28
股数
37,037
均价
$1.35
总金额
$50K
CARUSO JAMES V
President and CEO · Director
日期
Jun 5
股数
21,740
均价
$1.15
总金额
$25K
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 CLRB 内幕交易
CLRB 内幕交易
Cellectar Biosciences, Inc.（CLRB）内幕交易数据来源于公司内部人（包括Longcor Jarrod (COO), CARUSO JAMES V (CEO · Director), NEIS JOHN (Director)）提交的SEC Form 4申报文件。过去12个月内，4位内部人向SEC提交了交易申报。CLRB内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Cellectar Biosciences, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
CLRB 内幕交易 · 5个问题Cellectar Biosciences, Inc.（CLRB）的内部人包括高管和董事，如Longcor Jarrod (COO), CARUSO JAMES V (CEO · Director), NEIS JOHN (Director)等。过去12个月内，4位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026